Microsulis’s Acculis MTA product has again been suggested (IV message board) as a competitor for BSD Medical’s MTX-180. This is NOT so – as pointed out last year (see below). However, the Acculis MTA was, I believe, an impetus for BSD Medical to withhold introduction of their (then) recently FDA approved MTX-100. Before introducing the MTX-100, BSD M called in some oncology experts for “consultations” – actually, I believe, for demonstrating an improved, under-development model to those experts. The decision was then made to finish the MTX-180 development – a decision that delayed the first MTX product by about a year -- and the new development was well worth the wait! -- and quickly got an FDA approval.
The Microsulis product is highly lacking, compared to the MTX_180:
http://finance.yahoo.com/mbview/searchview/?q=Microsulis&in=b&bn=54bd2e95-2a9d-3046-b601-4c021ccc7e50&sa=&sm=&sbd=&sdf=dd/mm/yyyy&sdt=dd/mm/yyyy
>Re: Microsulis opened a $400,000 microwave manufacturing facility
By Ray_Bowman.Oct 31, 2011
>The “devil” is in the details. And, the important details (basic facts, actually) show that the Margulis unit IS competitive – with the MTX-100, NOT the MTX-180. From the Margulis website
http://www.microsulis.com/content.php?page=mtasystem
their Acculis MTA System:
does not have the much more advanced, highly-important synchronous phased array applicators and delivery system of the MTX-180
does not have a transparent applicator for greater visibility of the penetration area and thus safety from burns -- and providing high location precision
does not provide a NON-PERTURBING temperature probe (the Margulis unit uses ordinary metal-sheathed temperature probes, with long-known issues)
In other words, the Margulis unit is similar in capability (but still lacking an electrohyperthermia-suitable temperature monitor) to the MTX-100. Attention, you people who decried BSD M’s decision to withhold marketing of the MTX-100 in favor of finishing the development of the MTX-180 – do you now grasp why that decision was made? And, remember, that wise decision was made after consulting with some tumor ablation experts. (I believe one of those was probably DuPuy).<
An early user had this to say:
http://www.finanzen.net/nachricht/BSD-Medical-Announces-Success-in-Initial-Product-Launch-for-MicroThermX-Microwave-Ablation-System-981707
<Referring to his first patient treatment, James G. Carlisle, M.D., an interventional oncologist, stated, "BSD has hit the ball out of the park. The MicroThermX Microwave Ablation System provides multiple benefits, including quick set-up time, ease of use, and a big reduction in footprint. Of course, the ablation zones are large and predictable.”> |
